Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Auteurs principaux: | Mukhtyar, C, Luqmani, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2007
|
Documents similaires
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
par: Mukhtyar, C, et autres
Publié: (2008) -
Eular recommendations for vasculitis
par: Luqmani, R, et autres
Publié: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
par: Mukhtyar, C, et autres
Publié: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
par: Mukhtyar, C, et autres
Publié: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
par: Mukhtyar, C, et autres
Publié: (2009)